Literature DB >> 20926575

Excessive RNA splicing and inhibition of HIV-1 replication induced by modified U1 small nuclear RNAs.

Dibyakanti Mandal1, Zehua Feng, C Martin Stoltzfus.   

Abstract

HIV-1 RNA undergoes a complex splicing process whereby over 40 different mRNA species are produced by alternative splicing. In addition, approximately half of the RNA transcripts remain unspliced and either are used to encode Gag and Gag-Pol proteins or are packaged into virions as genomic RNA. It has previously been shown that HIV-1 splicing is regulated by cis elements that bind to cellular factors. These factors either enhance or repress definition of exons that are flanked by the HIV-1 3' splice sites. Here we report that expression of modified U1 snRNPs with increased affinity to HIV-1 downstream 5' splice sites and to sequences within the first tat coding exon act to selectively increase splicing at the upstream 3' splice sites in cotransfected 293T cells. This results in a decrease of unspliced viral RNA levels and an approximately 10-fold decrease in virus production. In addition, excessive splicing of viral RNA is concomitant with a striking reduction in the relative amounts of Gag processing intermediates and products. We also show that T cell lines expressing modified U1 snRNAs exhibit reduced HIV-1 replication. Our results suggest that induction of excessive HIV-1 RNA splicing may be a novel strategy to inhibit virus replication in human patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20926575      PMCID: PMC3004309          DOI: 10.1128/JVI.01257-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Reduction of target gene expression by a modified U1 snRNA.

Authors:  S A Beckley; P Liu; M L Stover; S I Gunderson; A C Lichtler; D W Rowe
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

Review 2.  Mechanisms of alternative pre-messenger RNA splicing.

Authors:  Douglas L Black
Journal:  Annu Rev Biochem       Date:  2003-02-27       Impact factor: 23.643

3.  Modified U1 snRNA suppresses expression of a targeted endogenous RNA by inhibiting polyadenylation of the transcript.

Authors:  Peng Liu; Mark Kronenberg; Xi Jiang; David Rowe
Journal:  Nucleic Acids Res       Date:  2004-03-03       Impact factor: 16.971

4.  Conserved stem-loop structures in the HIV-1 RNA region containing the A3 3' splice site and its cis-regulatory element: possible involvement in RNA splicing.

Authors:  S Jacquenet; D Ropers; P S Bilodeau; L Damier; A Mougin; C M Stoltzfus; C Branlant
Journal:  Nucleic Acids Res       Date:  2001-01-15       Impact factor: 16.971

5.  RNA splicing at human immunodeficiency virus type 1 3' splice site A2 is regulated by binding of hnRNP A/B proteins to an exonic splicing silencer element.

Authors:  P S Bilodeau; J K Domsic; A Mayeda; A R Krainer; C M Stoltzfus
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

6.  A block to human immunodeficiency virus type 1 assembly in murine cells.

Authors:  R Mariani; G Rutter; M E Harris; T J Hope; H G Kräusslich; N R Landau
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

7.  The sequence complementarity between HIV-1 5' splice site SD4 and U1 snRNA determines the steady-state level of an unstable env pre-mRNA.

Authors:  S Kammler; C Leurs; M Freund; J Krummheuer; K Seidel; T O Tange; M K Lund; J Kjems; A Scheid; H Schaal
Journal:  RNA       Date:  2001-03       Impact factor: 4.942

8.  Design of HIV vectors for efficient gene delivery into human hematopoietic cells.

Authors:  Priscilla Y Yam; Shulian Li; Jerry Wu; Jun Hu; John A Zaia; Jiing-Kuan Yee
Journal:  Mol Ther       Date:  2002-04       Impact factor: 11.454

9.  Efficient transcription through an intron requires the binding of an Sm-type U1 snRNP with intact stem loop II to the splice donor.

Authors:  Marina R Alexander; Adam K Wheatley; Rob J Center; Damian F J Purcell
Journal:  Nucleic Acids Res       Date:  2010-01-13       Impact factor: 16.971

10.  Inhibiting expression of specific genes in mammalian cells with 5' end-mutated U1 small nuclear RNAs targeted to terminal exons of pre-mRNA.

Authors:  Puri Fortes; Yolanda Cuevas; Fei Guan; Peng Liu; Sara Pentlicky; Stephen P Jung; Maria L Martínez-Chantar; Jesús Prieto; David Rowe; Samuel I Gunderson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-25       Impact factor: 12.779

View more
  14 in total

1.  Analysis of Competing HIV-1 Splice Donor Sites Uncovers a Tight Cluster of Splicing Regulatory Elements within Exon 2/2b.

Authors:  Anna-Lena Brillen; Lara Walotka; Frank Hillebrand; Lisa Müller; Marek Widera; Stephan Theiss; Heiner Schaal
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

2.  Tra2-mediated recognition of HIV-1 5' splice site D3 as a key factor in the processing of vpr mRNA.

Authors:  Steffen Erkelenz; Gereon Poschmann; Stephan Theiss; Anja Stefanski; Frank Hillebrand; Marianne Otte; Kai Stühler; Heiner Schaal
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

3.  An intronic G run within HIV-1 intron 2 is critical for splicing regulation of vif mRNA.

Authors:  Marek Widera; Steffen Erkelenz; Frank Hillebrand; Aikaterini Krikoni; Darius Widera; Wolfgang Kaisers; René Deenen; Michael Gombert; Rafael Dellen; Tanya Pfeiffer; Barbara Kaltschmidt; Carsten Münk; Valerie Bosch; Karl Köhrer; Heiner Schaal
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

4.  Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy.

Authors:  Robert J Scarborough; Kelsey L Adams; Olivier Del Corpo; Aïcha Daher; Anne Gatignol
Journal:  J Vis Exp       Date:  2016-09-05       Impact factor: 1.355

5.  An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects.

Authors:  Eugenio Fernandez Alanis; Mirko Pinotti; Andrea Dal Mas; Dario Balestra; Nicola Cavallari; Malgorzata E Rogalska; Francesco Bernardi; Franco Pagani
Journal:  Hum Mol Genet       Date:  2012-02-23       Impact factor: 6.150

6.  Sequence Analysis of In Vivo-Expressed HIV-1 Spliced RNAs Reveals the Usage of New and Unusual Splice Sites by Viruses of Different Subtypes.

Authors:  Yolanda Vega; Elena Delgado; Jorge de la Barrera; Cristina Carrera; Ángel Zaballos; Isabel Cuesta; Ana Mariño; Antonio Ocampo; Celia Miralles; Sonia Pérez-Castro; Hortensia Álvarez; Isabel López-Miragaya; Elena García-Bodas; Francisco Díez-Fuertes; Michael M Thomson
Journal:  PLoS One       Date:  2016-06-29       Impact factor: 3.240

7.  Argonaute proteins regulate HIV-1 multiply spliced RNA and viral production in a Dicer independent manner.

Authors:  Agathe Eckenfelder; Emmanuel Ségéral; Natalia Pinzón; Damien Ulveling; Céline Amadori; Marine Charpentier; Sabine Nidelet; Jean-Paul Concordet; Jean-François Zagury; Jean-Christophe Paillart; Clarisse Berlioz-Torrent; Hervé Seitz; Stéphane Emiliani; Sarah Gallois-Montbrun
Journal:  Nucleic Acids Res       Date:  2017-04-20       Impact factor: 16.971

8.  Roles of the linker region of RNA helicase A in HIV-1 RNA metabolism.

Authors:  Li Xing; Meijuan Niu; Xia Zhao; Lawrence Kleiman
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

9.  A Conserved Target Site in HIV-1 Gag RNA is Accessible to Inhibition by Both an HDV Ribozyme and a Short Hairpin RNA.

Authors:  Robert J Scarborough; Michel V Lévesque; Etienne Boudrias-Dalle; Ian C Chute; Sylvanne M Daniels; Rodney J Ouellette; Jean-Pierre Perreault; Anne Gatignol
Journal:  Mol Ther Nucleic Acids       Date:  2014-07-29       Impact factor: 10.183

10.  A functional conserved intronic G run in HIV-1 intron 3 is critical to counteract APOBEC3G-mediated host restriction.

Authors:  Marek Widera; Frank Hillebrand; Steffen Erkelenz; Ananda Ayyappan Jaguva Vasudevan; Carsten Münk; Heiner Schaal
Journal:  Retrovirology       Date:  2014-08-29       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.